Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure
Philippe Meyer(National and Kapodistrian University of Athens), Ali Ahmed(Linköping University), Marjan Mujib(National and Kapodistrian University of Athens), Michel White(Montreal Heart Institute), Vera Bittner(University of Alabama at Birmingham), Louis J. Dell’Italia(Birmingham VA Medical Center), Gilbert J. Perry(National and Kapodistrian University of Athens), Mustafa I. Ahmed(National and Kapodistrian University of Athens), Inmaculada Aban(National and Kapodistrian University of Athens), Ami E. Iskandrian(University of Alabama at Birmingham), Gerasimos Filippatos(National and Kapodistrian University of Athens)
Cited by 325
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k